Sandeep Laumas - Jul 12, 2021 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
Director
Signature
/s/ Sandeep Laumas
Stock symbol
UNCY
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
3
Date filed
7/12/2021, 05:12 PM
Previous filing
Jun 15, 2021
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding UNCY Common Stock 48.8K Jul 12, 2021 Direct
holding UNCY Common Stock 57K Jul 12, 2021 By Hilbert8 Investments LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UNCY Employee Stock Option (right to buy) Jul 12, 2021 Common Stock 11.6K $0.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the stock options vested on August 1, 2019, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on August 1, 2022.